重庆医学2023，Vol.52Issue(21)：3274-3278,3282,6.DOI:10.3969/j.issn.1671-8348.2023.21.013
PD-1单抗联合GC化疗治疗晚期尿路上皮癌的疗效及对肿瘤恶性程度的影响
Efficacy of PD-1 monoclonal antibody combined with GC chemotherapy in treating advanced urothelial carcinoma and its effect on tumor malignant degree
刘文辉 1沈宏亮1
作者信息
- 1. 首都医科大学附属北京友谊医院泌尿外科,北京 101125
- 折叠
摘要
关键词
程序性死亡受体-1单抗/吉西他滨/顺铂/尿路上皮癌/肿瘤恶性程度Key words
programmed death receptor-1 monoclonal antibody/gemcitabine/cisplatin/urothelial carcinoma/malignant degree of tumor分类
医药卫生引用本文复制引用
刘文辉,沈宏亮..PD-1单抗联合GC化疗治疗晚期尿路上皮癌的疗效及对肿瘤恶性程度的影响[J].重庆医学,2023,52(21):3274-3278,3282,6.
